Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01222104 · ClinicalTrials.gov registry record
Angio-Seal Interventional Radiology (IR) Registry
A clinical trial, sponsored by Abbott Medical Devices.
- Completed
- Registry status
- 634
- Enrollment target
NCT01222104: Completed study, sponsored by Abbott Medical Devices.
NCT01222104 is a clinical trial that has completed, run by Abbott Medical Devices. The registered enrollment target is 634 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01222104 has completed, sponsored by Abbott Medical Devices.
- COMPLETED
- Registry status
- 634 participants
- Enrollment target
Study Summary
The purpose of this study is to collect data on the standard of care use of the St. Jude Medical (SJM) Angio Seal™ Evolution™ and V-Twist Integrated Platform (VIP) Devices in diagnostic and/or interventional radiology patient populations.
Primary Outcome
Collect data on patients who have undergone a diagnostic and/or interventional radiology procedure in which the St. Jude Medical (SJM) Angio-Seal Evolution or V-Twist Integrated Platform (VIP) Device was deployed, to evaluate the rate of major vascular complications out to 30 days post-procedure. The following are defined as a major vascular complication: 1. Vascular injury requiring repair via surgery, angioplasty, ultrasound guided compression, thrombin injection, or other means; 2. Permanen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 634 participants |
| Start Date | 2010-10 |
| Est. Completion | 2011-05 |
What the finished NCT01222104 record still lists
NCT01222104 is an observational study that tracks outcomes without assigning an intervention. The registered 634 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01222104 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01222104 about?
NCT01222104 is a clinical study titled "Angio-Seal Interventional Radiology (IR) Registry". The purpose of this study is to collect data on the standard of care use of the St. Jude Medical (SJM) Angio Seal™ Evolution™ and V-Twist Integrated Platform (VIP) Devices in diagnostic and/or interventional radiology patient populations.
What is the current status of trial NCT01222104?
This trial is currently completed. The enrollment target is 634 participants. The study started on 2010-10. Estimated completion is 2011-05.
Who is sponsoring clinical trial NCT01222104?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573027 · 634 participants · NA
Heart Disease of the Small Arteries in Women and Men
- NCT04108156 · 634 participants · Phase 3
A Study to Evaluate Efficacy, Safety & Pharmacokinetics of the Port Delivery System (PDS) With Ranibizumab in Participants With Diabetic Macular Edema (DME) Compared With Intravitreal Ranibizumab; A Substudy to Evaluate the Safety of Re-implanting the PDS With Ranibizumab in Participants With DME
- NCT07237295 · 634 participants · NA
CommunityRx-Kidney Health
- NCT03478826 · 635 participants
Creation of a Biospecimen Repository From Patients With Interstitial Lung Diseases (ILD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia